Cybin (TSE:CYBN) has released an update.
Cybin Inc., a clinical-stage company focused on developing innovative treatments for mental health, has announced its participation in the Canaccord Genuity 44th Annual Growth Conference. CEO Doug Drysdale will engage in a fireside chat at the event, with both live webcast and archived viewing available for investors and interested parties.
For further insights into TSE:CYBN stock, check out TipRanks’ Stock Analysis page.
